UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 170

Sortiert nach

Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing

Antimicrobial agents and chemotherapy, 2018-02, Vol.62 (2)

2018

Volltextzugriff (PDF)

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper

Intensive care medicine, 2020-06, Vol.46 (6), p.1127-1153

2020

Volltextzugriff (PDF)

Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.309-316

2014

Volltextzugriff (PDF)

More codeine fatalities after tonsillectomy in North American children

Pediatrics (Evanston), 2012-05, Vol.129 (5), p.e1343

2012

Volltextzugriff (PDF)

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

The Lancet infectious diseases, 2014-06, Vol.14 (6), p.498-509

2014

Volltextzugriff (PDF)

Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin‐induced nephrotoxicity

Clinical and translational science, 2024-03, Vol.17 (3), p.e13764-n/a

2024

Volltextzugriff (PDF)

Interchangeability of generic drugs for subpopulations: Bioequivalence simulation from a nonparametric PK model of gabapentin generic drugs

British journal of clinical pharmacology, 2024-07, Vol.90 (7), p.1576-1585

2024

Volltextzugriff (PDF)

Development of a methodology to make individual estimates of the precision of liquid chromatography-tandem mass spectrometry drug assay results for use in population pharmacokinetic modeling and the optimization of dosage regimens

PloS one, 2020-03, Vol.15 (3), p.e0229873-e0229873

2020

Volltextzugriff (PDF)

Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence

Microbiology spectrum, 2024-02, Vol.12 (2), p.e0322223-e0322223

2024

Volltextzugriff (PDF)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children

Pharmaceutics, 2022-12, Vol.15 (1), p.75

2022

Volltextzugriff (PDF)

RPEM: Randomized Monte Carlo parametric expectation maximization algorithm

CPT: pharmacometrics and systems pharmacology, 2024-05, Vol.13 (5), p.759-780

2024

Volltextzugriff (PDF)

Optimizing Vancomycin Therapy in Critically Ill Children: A Population Pharmacokinetics Study to Inform Vancomycin Area under the Curve Estimation Using Novel Biomarkers

Pharmaceutics, 2023-04, Vol.15 (5), p.1336

2023

Volltextzugriff (PDF)

Relevance of pharmacokinetic and pharmacodynamic modeling to clinical care of critically ill patients

Current pharmaceutical biotechnology, 2011-12, Vol.12 (12), p.2044

2011

Volltextzugriff (PDF)

The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy

Current pharmaceutical design, 2014-01, Vol.20 (39), p.6191

2014

Volltextzugriff (PDF)

Software for Dosage Individualization of Voriconazole for Immunocompromised Patients

Antimicrobial Agents and Chemotherapy, 2013-04, Vol.57 (4), p.1888-1894

2013

Volltextzugriff (PDF)

Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)

Scientific reports, 2017-10, Vol.7 (1), p.14421-10, Article 14421

2017

Volltextzugriff (PDF)

An Algorithm for Nonparametric Estimation of a Multivariate Mixing Distribution with Applications to Population Pharmacokinetics

Pharmaceutics, 2020-12, Vol.13 (1), p.42

2020

Volltextzugriff (PDF)

Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R

Therapeutic drug monitoring, 2012-08, Vol.34 (4), p.467

2012

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents

Antimicrobial Agents and Chemotherapy, 2005-11, Vol.49 (11), p.4536-4545

2005

Volltextzugriff (PDF)

Transcriptome profiles of macrophages upon infection by morphotypic smooth and rough variants of Mycobacterium abscessus

Microbes and infection, 2024-07, Vol.26 (5-6), p.105367, Article 105367

2024

Volltextzugriff (PDF)

An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-02, Vol.22 (2), p.78-83

2016

Volltextzugriff (PDF)

Comparison of Four Renal Function Estimation Equations for Pharmacokinetic Modeling of Gentamicin in Geriatric Patients

Antimicrobial Agents and Chemotherapy, 2012-04, Vol.56 (4), p.1862-1869

2012

Volltextzugriff (PDF)

Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients

Pharmaceutics, 2021-12, Vol.13 (12), p.2170

2021

Volltextzugriff (PDF)

A pharmacokinetics‐based approach to the monitoring of patient adherence to atorvastatin therapy

Pharmacology research & perspectives, 2021-10, Vol.9 (5), p.e00856-n/a

2021

Volltextzugriff (PDF)

Roger W. Jelliffe, MD, FCP, FAAPS: A World Leader in Population Pharmacokinetic and Pharmacodynamic Modeling and Model-Based Target Controlled Individualized Dosing

Clinical pharmacology and therapeutics, 2021-01, Vol.109 (1), p.22-24

2021

Volltextzugriff (PDF)

1 – 25 von 170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(142)

Publikationsform

Sprache

Englisch
(169)
Japanisch
(26)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper

Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?

More codeine fatalities after tonsillectomy in North American children

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin‐induced nephrotoxicity

Interchangeability of generic drugs for subpopulations: Bioequivalence simulation from a nonparametric PK model of gabapentin generic drugs

Development of a methodology to make individual estimates of the precision of liquid chromatography-tandem mass spectrometry drug assay results for use in population pharmacokinetic modeling and the optimization of dosage regimens

Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children

RPEM: Randomized Monte Carlo parametric expectation maximization algorithm

Optimizing Vancomycin Therapy in Critically Ill Children: A Population Pharmacokinetics Study to Inform Vancomycin Area under the Curve Estimation Using Novel Biomarkers

Relevance of pharmacokinetic and pharmacodynamic modeling to clinical care of critically ill patients

The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy

Software for Dosage Individualization of Voriconazole for Immunocompromised Patients

Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)

An Algorithm for Nonparametric Estimation of a Multivariate Mixing Distribution with Applications to Population Pharmacokinetics

Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R

Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents

Transcriptome profiles of macrophages upon infection by morphotypic smooth and rough variants of Mycobacterium abscessus

An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity

Comparison of Four Renal Function Estimation Equations for Pharmacokinetic Modeling of Gentamicin in Geriatric Patients

Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients

A pharmacokinetics‐based approach to the monitoring of patient adherence to atorvastatin therapy

Roger W. Jelliffe, MD, FCP, FAAPS: A World Leader in Population Pharmacokinetic and Pharmacodynamic Modeling and Model-Based Target Controlled Individualized Dosing

Suchergebnisse filtern